Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein–Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial
Titel:
Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein–Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial
Auteur:
Mahadeo, Kris Michael Baiocchi, Robert Beitinjaneh, Amer Chaganti, Sridhar Choquet, Sylvain Dierickx, Daan Dinavahi, Rajani Duan, Xinyuan Gamelin, Laurence Ghobadi, Armin Guzman-Becerra, Norma Joshi, Manher Mehta, Aditi Navarro, Willis H Nikiforow, Sarah O'Reilly, Richard J Reshef, Ran Ruiz, Fiona Spindler, Tassja Prockop, Susan